Arex Advisor

Executive Summary

Arex Advisor is a Stockholm-based regulatory consultancy founded in 2020, serving the life sciences sector including pharma, biotech, and medtech companies. The firm specializes in navigating complex EU regulatory landscapes, offering cross-functional expertise from development through commercialization to ensure compliance, manage risks, and accelerate market entry. As regulatory frameworks in Europe become increasingly stringent—such as the EU Medical Device Regulation (MDR) and evolving clinical trial requirements—Arex Advisor is well-positioned to capture demand from companies seeking specialized guidance. The company's focus on EU-specific regulations gives it a niche advantage, particularly for small and mid-size firms lacking in-house regulatory capabilities. With a lean team and no disclosed funding, Arex Advisor operates as a private, bootstrapped entity, suggesting a conservative growth model. However, the increasing complexity of life sciences regulation in Europe and the post-Brexit environment create tailwinds for regulatory service providers. Arex Advisor's ability to scale will depend on hiring top talent and leveraging technology to standardize processes, though no concrete pipeline or traction data is available.

Upcoming Catalysts (preview)

• Q4 2026EU Pharmaceutical Legislation Revision Implementation70% success
• TBDPartnership with Medtech or Pharma Accelerator Programs40% success
• TBDExpansion of Service Offerings into AI Regulatory Consulting50% success